🔗 Share this article Social Media Content Creators Driving Unofficial Market for Unlicensed Slimming Drug An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings. Investigational Drug Gaining Traction Online The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes. Thriving Trade on Messaging Platforms Separately, a robust market exists on messaging services, where communities with numerous of members share comparison photos, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before directing buyers to other platforms for purchases. Understanding Retatrutide Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic. Healthcare Experts Express Worries Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting substances of uncertain source. Some professionals said the demand for the experimental drug could be linked to the increasing price of approved weight loss treatments such as Mounjaro. Regulatory Position and Enforcement Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012. Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, advertising, and consumer regulations, risking penalties, prosecution or prison. Platform Response and Material Removal According to the social media company, the platform has removed problematic material and prohibited related hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform secure and investing in enhancing compliance measures. Digital Marketplace Activities Investigations also discovered communities with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, populated with photos of weight loss, positive testimonials and detailed guides for preparing or administering at home. Within moments of joining one group, a seller posted WhatsApp details, where most purchases occur. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, medical conditions or past usage. Item Information and Pricing Inside these communities, posts display black plastic packages with postal service stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.” Customers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”. Service Moderation and Security Measures A representative for the messaging service said it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”. Healthcare Expert Warnings “People are injecting substances they can’t verify. Even if the science behind retatrutide is valid, these online versions may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U. Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained. Her staff has previously encountered individuals injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.” Manufacturer Position A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company experimental substance not yet approved … may subject patients to potentially serious health risks”.